慶應医学会例会

下記のとおり例会を開催いたしますので、ふるってご来聴くださいますようお願い申し上げます。

日 時 2019 年 8 月 19 日 (月) 17 : 00
場 所 総合医科学研究棟1階ラウンジ
演 題

Transcriptional programs underlying T cell exhaustion: Nr4a limits CAR T cell function in solid tumors

  Joyce Chen MD/PhD
La Jolla Institute
参考 固形癌のCAR-T療法におけるT細胞疲弊の分子機構の解明の話。
Nature. 2019 Mar;567(7749):530-534.
NR4A transcription factors limit CAR T cell function in solid tumours.
担 当

微生物学・免疫学教室 教室
責任者:吉村 昭彦 教授
担当者:(内線 61220)

 
  以上
日 時 2019 年 7 月 10 日 (水) 17 : 00
場 所 1号館2階カンファレンスルーム2
演 題

Surgical training and research in the Netherlands

  Bas P.L. Wijnhoven MD PhD
Erasmus University Medical Center Rotterdam The Netherlands
  In contrast to many other countries, training of medical specialists is funded by the Department of Health. The curriculum of medical specialist training including general surgery is well structured and lasts 5-6 years. Specialist (trainers) and hospitals involved in surgical training have been accredited by the Dutch Association of Surgeons. Surgical training includes 4 years of general surgery followed by two years of differentiation in one of the sub-specialities. These are gastrointestinal, oncological, vascular, pediatric and trauma surgery. The training program is competency based: there are key procedures and so called EPA (entrusted professional activities) that are defined to monitor the progress of an individual. Unique in the Dutch system is the quality control and governance of surgical training that will be discussed in my lecture.
The number of positions available for surgical trainees is limited and determined by the government each year. Hence, to enter surgical training has always been very competitive and not easy for young doctors. This is one of the reasons why many students start a PhD program after medical school and to gain experience in basic or clinical research. These young and talented students usually work for 3-4 years full time and are well capable of coordinating trials. This is just one of the reasons that many clinical (randomised) studies come from the Netherlands. Besides this strong academic environment, lack of private practice, strong multidisciplinary working parties and the geographical situation in our small country facilitates multicenter studies. Some more crucial factors for success will be discussed in the lecture.
 
担 当

外科学(一般・消化器) 教室
責任者:北川雄光 教授
担当者:真柳修平 先生(内線 62334)

 
  以上
日 時 2019 年 7 月 8 日 (月) 18 : 30
場 所 リサーチパーク1階 ラウンジ
演 題

Rapidly evolving strategies for the treatment of liver cancer

  Dan G Duda D.M.D., Ph.D.
Massachusetts General Hospital Research Institute, Harvard Medical School
担 当

外科学 教室
責任者:北川 雄光 教授
担当者:茂田 浩平 先生(内線 62234)

 
  以上
日 時 2019 年 6 月 25 日 (火) 17 : 30
場 所 総合医科学研究棟2階会議室
演 題

Dementia care and research - What a difference a decade makes?

  Louise Robinson Professor
Newcastle University Institute of Ageing
  Dementia care currently costs the UK 21 bn pounds a year, and that doesn't include the huge informal costs of family careers and community support networks. Developing services to meet the needs of patients with complex health problems must involve service users. Professor Robinson has addressed what resources are needed to provide a better quality of care, and how these can be successfully delivered to patients and their family. As Newcastle University's Professor of Primary Care and Ageing, and as a working GP in a Newcastle practice, she is keen to ensure that the benefits of the University's excellent research into ageing and the diseases of old age are translated into high quality treatment and care for older people. She leads the Primary Care Group of the Dementia and Neurodegenerative Diseases Research Network (DeNDRoN), a national network of researchers which aims to explore the whole spectrum of dementia care from diagnosis and early detection, through to advanced dementia and end of life care. Another Professor Robinson's ambitions would be to help create a center of excellence at Newcastle University for training GPs, hospital staff, community nurses and others in all aspects of dementia care. In this lecture, Prof Robinson will talk about how her translational research had influenced UK practice over the last 10+ years and at same time bring in her career development in both clinical and academic field.  
担 当

総合診療科 教室
責任者:藤島 清太郎 准教授
担当者:新井 康通 先生(内線 62855)

 
  以上
日 時 2019 年 5 月 10 日 (金) 17 : 00
場 所 東校舎1階会議室
演 題

Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation.

  三澤拓馬
University of Texas Southwestern (UTSW) Medical Center
Center for the Genetics of Host Defense
(ノーベル賞受賞のBruce Beutler研究室)研究員
  変異マウスを用いたフォワード・ジェネティクススクリーニングによって、Immunoglobulin E (IgE) の産生に関わる遺伝子の特定を試みた。その結果、Ser/Thr kinase であるProtein kinase D2 (Prkd2)が、IgE 産生機構の負の制御因子であることが明らかとなった。Prkd2 変異 マウスにおけるIgE の異常な産生は、T follicular helper cells (TFH) の過度の分化に起因していた。
未刺激条件下のCD4+ T細胞において、Prkd2 はTFH のマスターレギュレーターであるB-cell lymphoma 6 (Bcl6)をリン酸化する。リン酸化型Bcl6は核へスムーズに移行できないため、TFHの分化が抑制される。一方、アレルゲン感作によってCD4+ T細胞におけるBcl6 の発現量が高まると、Bcl6 は自身の転写抑制活性によってPrkd2 の転写量を低下させる。Prkd2 の発現量が減少すると、CD4+ T 細胞内には非リン参加型のBcl6 が蓄積し、それらは核内へ移行する。Bcl6 は、核内においてTFH の分化を促進するための遺伝子制御を行う。つまり、本研究によってPrkd2-Bcl6 間の相互制御のバランスが、TFH の分化とその後のIgE の産生量を適切に保つ上で極めて重要であることが明らかとなった。
担 当

微生物学・免疫学教室 教室
責任者:吉村 昭彦 教授
担当者:(内線 61220)

 
  以上
日 時 2019 年 4 月 16 日 (火) 15 : 00
場 所 総合医科学研究棟2階会議室
演 題

Stem cells of the suture mesenchyme in craniofacial bone development, repair and regeneration

  Takamitsu Maruyama PhD
  University of Rochester Medical Center
  Development of the skeleton is mediated through two distinct ossification mechanisms. Craniofacial bones are formed mainly through intramembranous ossification, a mechanism different from endochondral ossification required for development of the body skeleton. The skeletal structures are quite distinct between the two, thus they are likely to have their unique stem cell populations. The sutures serve as the growth center critical for healthy development of the craniofacial skeleton. Defects in suture morphogenesis cause its premature closure, resulting in development of craniosynostosis, a devastating disease affecting 1 in ~2,500 individuals. The suture mesenchyme has been postulated to act as the niche of skeletal stem cells essential for calvarial morphogenesis. However, very limited knowledge is available for suture biology and suture stem cells (SuSCs) have yet to be isolated. Here we report the first evidence for identification and isolation of a stem cell population residing in the suture midline. Genetic labeling of SuSCs shows their ability to self-renew and continually give rise to mature cell types over a 1-year monitoring period. They maintain their localizationin the niches constantly produce skeletogenic descendants during calvarial development and homeostastic maintenance. Upon injury, SuSCs expand drastically surrounding the skeletogenic mesenchyme, migrate to the damaged site and contribute directly to skeletal repair in a cell autonomous fashion. The regeneration, pluripotency and frequency of SuSCs are also determined using limiting dilution transplantation. In vivo clonal expansion analysis demonstrates a single SuSC capable of generating bones. Furthermore, SuSC transplantation into injured calvaria facilitates the healing processes through direct engraftments. Our findings demonstrate SuSCs are bona fide skeletal stem cells ideally suited for cell-based craniofacial bone therapy as they possess abilities to engraft, differentiate.

担当・責任者:
共同利用研究室(細胞組織学)
松尾光一 教授(内線 62580)

 
  以上

†先頭へ

関連病院会 クリニック情報 住所変更依頼 トップページへ戻る